MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


0026-895X/04/6505-1070-1079$20.00
Mol Pharmacol 65:1070-1079, 2004

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Findlay, V. J.
Right arrow Articles by Tew, K. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Findlay, V. J.
Right arrow Articles by Tew, K. D.

Tumor Cell Responses to a Novel Glutathione S-Transferase–Activated Nitric Oxide-Releasing Prodrug

Victoria J. Findlay, Danyelle M. Townsend, Joseph E. Saavedra, Gregory S. Buzard, Michael L. Citro, Larry K. Keefer, Xinhua Ji, and Kenneth D. Tew

Department of Pharmacology, Fox Chase Cancer Center, Philadelphia, Pennsylvania (V.J.F., D.M.T., K.D.T.); Basic Research Program, SAIC-Frederick, Frederick, Maryland (J.E.S., G.S.B., M.L.C.); and Laboratory of Comparative Carcinogenesis (L.K.K.) and Macromolecular Crystallography Laboratory (X.J.), National Cancer Institute at Frederick, Frederick, Maryland

We have used structure-based design techniques to introduce the drug O2-[2,4-dinitro-5-(N-methyl-N-4-carboxyphenylamino) phenyl] 1-N,N-dimethylamino)diazen-1-ium-1,2-diolate (PABA/NO), which is efficiently metabolized to potentially cytolytic nitric oxide by the {pi} isoform of glutathione S-transferase, an enzyme expressed at high levels in many tumors. We have used mouse embryo fibroblasts (MEFs) null for GST{pi} (GST{pi}-/-) to show that the absence of GST{pi} results in a decreased sensitivity to PABA/NO. Cytotoxicity of PABA/NO was also examined in a mouse skin fibroblast (NIH3T3) cell line that was stably transfected with GST{pi} and/or various combinations of {gamma}-glutamyl cysteine synthetase and the ATP-binding cassette transporter MRP1. Overexpression of MRP1 conferred the most significant degree of resistance, and in vitro transport studies confirmed that a GST{pi}-activated metabolite of PABA/NO was effluxed by MRP1 in a GSH-dependent manner. Additional studies showed that in the absence of MRP1, PABA/NO activated the extracellular-regulated and stress-activated protein kinases ERK, c-Jun NH2-terminal kinase (JNK), and p38. Selective inhibition studies showed that the activation of JNK and p38 were critical to the cytotoxic effects of PABA/NO. Finally, PABA/NO produced antitumor effects in a human ovarian cancer model grown in SCID mice.


Received October 2, 2003; accepted January 22, 2004

Address correspondence to: Kenneth D. Tew, Department of Pharmacology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111. E-mail: kd_tew{at}fccc.edu




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
D. M. Townsend, Y. Manevich, L. He, S. Hutchens, C. J. Pazoles, and K. D. Tew
Novel Role for Glutathione S-Transferase {pi}: REGULATOR OF PROTEIN S-GLUTATHIONYLATION FOLLOWING OXIDATIVE AND NITROSATIVE STRESS
J. Biol. Chem., January 2, 2009; 284(1): 436 - 445.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. M. Townsend, L. He, S. Hutchens, T. E. Garrett, C. J. Pazoles, and K. D. Tew
NOV-002, a Glutathione Disulfide Mimetic, as a Modulator of Cellular Redox Balance
Cancer Res., April 15, 2008; 68(8): 2870 - 2877.
[Abstract] [Full Text] [PDF]


Home page
Mol. Interv.Home page
D. M. Townsend
S-Glutathionylation: Indicator of Cell Stress and Regulator of the Unfolded Protein Response
Mol. Interv., December 1, 2007; 7(6): 313 - 324.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. M. Moyer, O. E. Salavaggione, S. J. Hebbring, I. Moon, M. A.T. Hildebrandt, B. W. Eckloff, D. J. Schaid, E. D. Wieben, and R. M. Weinshilboum
Glutathione S-Transferase T1 and M1: Gene Sequence Variation and Functional Genomics
Clin. Cancer Res., December 1, 2007; 13(23): 7207 - 7216.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
V. J. Findlay, D. M. Townsend, T. E. Morris, J. P. Fraser, L. He, and K. D. Tew
A Novel Role for Human Sulfiredoxin in the Reversal of Glutathionylation.
Cancer Res., July 1, 2006; 66(13): 6800 - 6806.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
D. M. Townsend, V. J. Findlay, F. Fazilev, M. Ogle, J. Fraser, J. E. Saavedra, X. Ji, L. K. Keefer, and K. D. Tew
A Glutathione S-Transferase {pi}-Activated Prodrug Causes Kinase Activation Concurrent with S-Glutathionylation of Proteins
Mol. Pharmacol., February 1, 2006; 69(2): 501 - 508.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
K. D. Tew, J. T. Boyd, Z. J. Chen, W. Davis Jr., F. Fazilev, V. Findlay, L. Gate, K. Ile, A. Soulika, and D. M. Townsend
Glutathione and ABC Transporters as Determinants of Sensitivity to Oxidative and Nitrosative Stress
J. Nutr., November 1, 2004; 134(11): 3205S - 3206S.
[Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics